My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 135

    1.

    Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006.

    Modabber F, Buffet PA, Torreele E, Milon G, Croft SL.

    Kinetoplastid Biol Dis. 2007 Apr 24;6:3.PMID: 17456237 [PubMed]Related articlesFree article

    2.

    Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis.

    Ghalib H, Modabber F.

    Kinetoplastid Biol Dis. 2007 Aug 17;6:7.PMID: 17705861 [PubMed - in process]Related articlesFree article

    3.

    Procedures and methods of benefit assessments for medicines in Germany.

    Bekkering GE, Kleijnen J.

    Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29.PMID: 18987905 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Procedures and methods of benefit assessments for medicines in Germany]

    Bekkering GE, Kleijnen J.

    Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. Epub 2008 Nov 25. German. PMID: 19034813 [PubMed - indexed for MEDLINE]Related articles

    5.

    Leishmaniasis: recognition and management with a focus on the immunocompromised patient.

    Choi CM, Lerner EA.

    Am J Clin Dermatol. 2002;3(2):91-105. Review.PMID: 11893221 [PubMed - indexed for MEDLINE]Related articles

    6.

    Interventions for Old World cutaneous leishmaniasis.

    González U, Pinart M, Reveiz L, Alvar J.

    Cochrane Database Syst Rev. 2008 Oct 8;(4):CD005067. Review.PMID: 18843677 [PubMed - indexed for MEDLINE]Related articles

    7.

    How to anticipate the assessment of the public health benefit of new medicines?

    Massol J, Puech A, Boissel JP; Participants inRound Table No 7, Giens XXII.

    Therapie. 2007 Sep-Oct;62(5):427-35. Epub 2008 Jan 19.PMID: 18206104 [PubMed - indexed for MEDLINE]Related articles

    8.

    Situational analysis of leishmaniases research in Kenya.

    Tonui WK.

    Afr J Health Sci. 2006 Jan-Jun;13(1-2):7-21.PMID: 17348738 [PubMed - indexed for MEDLINE]Related articles

    9.

    Leishmaniasis: current treatment and prospects for new drugs and vaccines.

    Kedzierski L, Sakthianandeswaren A, Curtis JM, Andrews PC, Junk PC, Kedzierska K.

    Curr Med Chem. 2009;16(5):599-614. Review.PMID: 19199925 [PubMed - indexed for MEDLINE]Related articles

    10.

    Topical chemotherapy of cutaneous Leishmaniasis.

    Ei-On J, Jacobs GP, Weinrauch L.

    Parasitol Today. 1988 Mar;4(3):76-81.PMID: 15463047 [PubMed]Related articles

    11.
    12.

    INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

    [No authors listed]

    Drugs R D. 2007;8(3):176-87. Review.PMID: 17472413 [PubMed - indexed for MEDLINE]Related articles

    13.

    Interventions for American cutaneous and mucocutaneous leishmaniasis.

    González U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA.

    Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004834. Review.PMID: 19370612 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994-95.

    Sharifi I, Fekri AR, Aflatonian MR, Nadim A, Nikian Y, Kamesipour A.

    Bull World Health Organ. 1998;76(3):289-93.PMID: 9744249 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Advances in battle against leishmaniasis.

    [No authors listed]

    TDR News. 1998 Oct;(57):2.PMID: 12294756 [PubMed - indexed for MEDLINE]Related articles

    16.

    Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.

    Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, Malow R, McClellan WM.

    Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. Review.PMID: 18646068 [PubMed - indexed for MEDLINE]Related articles

    17.

    Leishmaniasis: current situation and new perspectives.

    Desjeux P.

    Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):305-18. Review.PMID: 15225981 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management.

    Ameen M.

    Expert Opin Pharmacother. 2010 Mar;11(4):557-69.PMID: 20163267 [PubMed - in process]Related articles

    19.

    Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

    Tuon FF, Amato VS, Graf ME, Siqueira AM, Nicodemo AC, Amato Neto V.

    Int J Dermatol. 2008 Feb;47(2):109-24. Review.PMID: 18211479 [PubMed - indexed for MEDLINE]Related articles

    20.

    Discovery of novel vaccine candidates and drug targets against visceral leishmaniasis using proteomics and transcriptomics.

    Kumari S, Kumar A, Samant M, Singh N, Dube A.

    Curr Drug Targets. 2008 Nov;9(11):938-47. Review.PMID: 18991606 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk